David B Thompson

This inventor holds 22 USPTO granted patents and 11 published patent applications and 3 EPO patents, primarily in Gene Editing Technologies. Top assignees: Harvard College, Massachusetts Eye and Ear Infirmary, Other. Active years: 1993-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David B Thompson. Retrieved from https://idiyas.com/inventor/david-b-thompson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 11)

% Patents Active = 95.5

EPO Patents = 3 (Patent Applications = 11)

Average Co-Inventor Count = 3.3

ph-index = 11

Forward Citations = 904(Granted Patents)

Location History:

Conifer, CO (US) (1993)
Pendleton, OR (US) (1996)
Tallahassee, FL (US) (2004)
Brookline, MA (US) (2021)
Cambridge, MA (US) (2015 - 2024)

Company Filing History:

Massachusetts Eye and Ear Infirmary

patents

2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1993-2026

Loading Chart...

Areas of Expertise:

Cas9 Variants

Gene Editing

Therapeutic Molecules

Cationic Lipids

Site-Specific Recombination

Nuclease Delivery

Cell Penetration

Fusion Proteins

Inner Ear Delivery

Functional Nucleases

Protein Delivery

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12584118 - CAS9 VARIANTS AND USES THEREOF (2026-03-24),

2. 12559737 - CAS9 VARIANTS AND USES THEREOF (2026-02-24),

3. 12102691 - Methods for efficient delivery of therapeutic molecules in vitro and in vivo (2024-10-01),

4. 12043653 - Efficient delivery of therapeutic molecules to cells of the inner ear (2024-07-23),

5. 11905623 - Evolution of site-specific recombinases (2024-02-20),

6. 11370823 - Efficient delivery of therapeutic molecules to cells of the inner ear (2022-06-28),

7. 11104967 - Evolution of site-specific recombinases (2021-08-31),

8. 11071790 - Method for efficient delivery of therapeutic molecules in vitro and in vivo (2021-07-27),

9. 10912833 - Delivery of negatively charged proteins using cationic lipids (2021-02-09),

10. 10858639 - CAS9 variants and uses thereof (2020-12-08),

11. 10682410 - Delivery system for functional nucleases (2020-06-16),

12. 10392674 - Evolution of site-specific recombinases (2019-08-27),

13. 10258697 - Efficient delivery of therapeutic molecules in vitro and in vivo (2019-04-16),

14. 9999671 - Delivery of negatively charged proteins using cationic lipids (2018-06-19),

15. 9737604 - Use of cationic lipids to deliver CAS9 (2017-08-22),

Title: The Innovative Journey of David B Thompson

Introduction: David B Thompson, a pioneering inventor based in Cambridge, MA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: David B Thompson's latest patents include a cutting-edge software application for data encryption and a revolutionary medical device for non-invasive glucose monitoring.

Career Highlights: With a career spanning over two decades, David B Thompson has established himself as a leading figure in the tech industry, holding multiple patents in various sectors such as cybersecurity, healthcare, and artificial intelligence.

Collaborations: Throughout his career, David B Thompson has collaborated with top research institutions, leading companies, and renowned universities to further develop and implement his innovative ideas, solidifying his reputation as a visionary inventor.

Conclusion: David B Thompson's relentless pursuit of innovation and his passion for creating solutions to complex challenges have cemented his legacy as a trailblazing inventor in the ever-evolving world of technology.

Profile summary based on public USPTO records.